Stock listing
Concord Biotech Ltd.
Selected listing: CONCORDBIO · NSE · INR · IN
Concord Biotech Ltd. (NSE:CONCORDBIO), Commercial Services. Latest release Jun 25, 2026: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection…
- Ticker
- NSE:CONCORDBIO
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NSE
- Currency
- INR
About Concord Biotech Ltd.
Concord Biotech Ltd. is a public company listed under the ticker CONCORDBIO, operating in the Indian market. Concord Biotech focuses on biotechnology and pharmaceutical development, contributing to advancements in healthcare solutions.
Latest news from Concord Biotech Ltd.
Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
June 25, 2026
Bertelsmann says US authorities have approved BMG/Concord merger
June 17, 2026
Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
June 12, 2026
Trade Spotlight: How should you trade Concord Biotech, Jindal Steel, Axis Bank, Aegis Logistics, Raymond, and others on June 11?
June 10, 2026
Concord Biotech surges over 5% after USFDA approval for Tofacitinib tablets
June 10, 2026
Research Concord Biotech Ltd.
Concord Biotech Ltd. company profile
View the public company page for Concord Biotech Ltd. on 6ix.
Concord Biotech Ltd. news
Read company news and market updates connected to Concord Biotech Ltd..
Concord Biotech Ltd. investor events
Find investor webinars, events, and replay context for Concord Biotech Ltd..